Lundbeck
HLUN-B.CO
#2868
Rank
C$5.97 B
Marketcap
$6.22
Share price
7.19%
Change (1 day)
-3.36%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2024 (TTM): C$0.76 Billion

According to Lundbeck 's latest financial reports the company's current earnings are C$3.18 Billion. , an increase over its 2023 earnings that were of C$0.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2024

Annual earnings

Year Earnings Change
2024 C$0.76 B25.46%
2023 C$0.61 B21.69%
2022 C$0.50 B31.79%
2021 C$0.38 B-4.53%
2020 C$0.40 B-45.08%
2019 C$0.72 B-33.97%
2018 C$1.10 B12.76%
2017 C$0.97 B94.32%
2016 C$0.50 B-136.98%
2015 -C$1.37 Billion-1258.1%
2014 C$0.11 B-72.43%
2013 C$0.42 B4.31%
2012 C$0.40 B-55.26%
2011 C$0.91 B6.64%
2010 C$0.85 B-6.68%
2009 C$0.91 B